The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway
Department of Oncology, Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome
Guangdong‐Hong Kong‐Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine
Department of Oncology, Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome
Guangdong‐Hong Kong‐Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine
Department of Oncology, Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome
Guangdong‐Hong Kong‐Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine
Department of Oncology, Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome
Guangdong‐Hong Kong‐Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine
Department of Oncology, Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome
Guangdong‐Hong Kong‐Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine